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1. Introduction 
Recently, we have been interested in a systematic 
study of the behaviour of L-nucleosides and nucleo- 
tides. These compounds, enantiomers of the naturally 
occurring nucleic acid components, are now easily 
accessible by unequivocal synthetic procedures [l-3] 
which eliminate any possibility of contamination by 
natural derivatives. On investigation of numerous 
enzymes and enzymatic systems in vitro it has been 
demonstrated [3,4] that the nucleotide derivatives 
of the L-ribo series are resistant towards many nucle- 
olytic enzymes as determined by the mode of binding 
of the nucleoside residue to the enzyme molecule. 
This observation led us to investigate the biochemical 
properties of L-nucleosides in uivo. The experiments 
with bacterial cells showed that there is essentially no 
transport of L-ribonucleosides through the cell wall 
of the bacteria investigated [S] . Thereafter, we 
examined the possibility of L-nucleoside utilization in 
mammalian tissue systems in viva. In this paper we 
report the results obtained with L-adenosine applied 
intraperitoneally to mice. 
2. Material and methods 
8-3H-L-adenosine was prepared by an alkali- 
catalyzed tritium-exchange reaction [6] of L-adeno- 
sine [l] in tritium oxide. The product thus obtained 
(specific activity 37.5 mCi/mmole) was essentially free 
of adenine (as shown by borate buffer electrophoresis) 
and chromatographically homogeneous. This compound 
* To whom requests for reprints should be addressed. 
was administered intraperitoneally to a mouse 
(“H”-strain) in one dose of 36.6 PCi. 
Simultaneously, the same experiment was per- 
formed with a leukemic animal (5 days after leukemic 
inoculation). 
3. Results 
The excretion of radioactivity in urine of experi- 
mental animals (fig. 1) shows a remarkable time delay 
in L-nucleoside excretion. Moreover, the difference 
between healthy and leukemic animals favours the 
accumulation of L-nucleoside in the latter. The paper 
chromatographic analysis of urine constituents showed 
that about 97% of the radioactive material consisted 
of L-adenosine, the residual activity being formed by 
L-inosine. There were no traces of adenine within the 
range of experimental error. 
The distribution of labelled L-adenosine in samples 
from various tissues was analyzed by direct counting 
in liquid scintillation apparatus. The data summarized 
in table 1 show the distribution of L-nucleoside in 
different tissues. It might be pointed out that the 
content of L-nucleoside is significantly higher in 
leukemic tissues. 
On analyzing the tissue homogenates, the main 
part of the radioactivity was found in a 70% ethanol 
soluble fraction, the content being again remarkably 
higher with leukemic tissues. The pool was analyzed 
for nucleotide content by paper chromatography in 
2-propanol-concentrated aqueous ammonia-water 
(7: 1:2) system. In most tissues examined (table 2) 
the material contained small but detectable amounts 
of L-AMP. The only exception was found with liver 
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Table 1 
Distribution of L-adenosine in mice tissues (cpm)a. 
Time after 
administration (hr) 
Liver 
N L 
Spleen Thymus 
N L N L 
0.5 17,400 22,500 31,800 43.100 29,400 43,500 
1.0 8,100 15,000 7,800 16,200 7,200 20,400 
2.0 2,000 8,600 2,400 9,000 2,700 10,500 
3.0 1,500 6,900 1,450 6,900 1,800 8,400 
6.0 1,150 6,050 1,290 3,900 900 5,400 
11.0 930 1,700 1,050 1,806 900 2.550 
24.0 900 997 750 1,350 750 1,050 
a Values for 10 mg of wet tissues; N = normal, L = leukemic. 
homogenate he pool fraction of which contained up 
to 40% L-AMP. The enantiomeric purity of this 
material was checked by treatment with the whole 
snake venom (K russelli) which did not afford any 
significant amount of nucleoside material (L-nucleo- 
side ?-phosphates are not dephosphorylated bysnake 
venom 5’nucleotidase [3] ). Both this enantiomeric 
purity of labelled nucleotide and the analysis of 
Gadenosine fraction of the same sample which did 
not reveal any trace of labelled adenine liminate the 
possibility of L-adenosine utilization for the synthesis 
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Fig. 1. Excretion of L-adenosine’H in mouse urine. Values 
refer to percentage of radioactivity excreted as function of 
time (administered ose = 100%). (1) Normal, (2) leukemic, 
of natural nucleosides de nwo under the experimental 
conditions. 
On detailed analysis by citrate buffer (pH 3.5) 
electrophoresis, the nucleotidic fraction of liver 
homogenate was shown to contain 2% L-ADP in addi- 
tion to the bulk of L-AMP discussed above. On the 
other hand, the presence of L-ATP could not be 
proven within the limits of experimental error. L-AMP 
seems to be a substrate for nucleotide kinases of liver 
cells. In this connection, L-adenosine incorporation into 
liver RNA was to be examined. The TCA insoluble 
fraction of liver homogenate contains a significant 
amount of L-adenosine, dependent upon the quantity 
of the material applied. From the estimation of.the 
radioactivity of native liver RNA [7] it follows that 
there is 0.015 mol. % L-adenosine residue incorporated 
Table 2 
Phosphorylation of L-adenosine in mice tissues. 
Total radioactivitya 
(cpm) L-AMP (%) Tissues 
N L N L 
Thymus 
Spleen 
Liver 
Brain 
Kidney 
Muscle 
Heart 
Blood 
19,800 24,200 3.5 
18,200 16,600 5.0 
36,800 28,000 45.0 
4,950 6,450 traces 
49,500 70,050 none 
1,950 3,200 none 
1,050 1,100 none 
30,200 36,000 8.0 
3.5 
6.5 
43.0 
traces 
none 
none 
none 
7.0 
Time after administration, 1.30 hr. 
a For 25 mg of wet tissues, N = normal, L = leukemic. 
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into liver RNA. The character of its linkages as well as 
the detailed analysis of the incorporarion into RNA 
are under study. 
PI 
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